HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David L Veenstra Selected Research

Cytochrome P-450 CYP2C9

1/2017Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting.
6/2015Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.
9/2008Warfarin pharmacogenetics.
8/2008An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
7/2004Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs.
4/2002Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David L Veenstra Research Topics

Disease

13Hemorrhage
01/2020 - 04/2002
11Neoplasms (Cancer)
01/2022 - 03/2002
6Disease Progression
01/2022 - 12/2002
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2008
6Breast Neoplasms (Breast Cancer)
01/2015 - 07/2004
5Chronic Hepatitis B
03/2008 - 01/2007
4Stroke (Strokes)
01/2017 - 05/2002
4Thrombosis (Thrombus)
08/2016 - 02/2012
4Infections
05/2009 - 06/2002
4Sepsis (Septicemia)
11/2004 - 06/2002
3Melanoma (Melanoma, Malignant)
12/2021 - 01/2019
3Opiate Overdose
11/2021 - 10/2019
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2021 - 10/2018
3Heart Failure
08/2019 - 11/2009
3Ischemic Stroke
01/2017 - 01/2013
2Lennox Gastaut Syndrome
01/2021 - 11/2020
2Drug-Related Side Effects and Adverse Reactions
01/2021 - 04/2002
2Seizures (Absence Seizure)
01/2021 - 11/2020
2Hepatocellular Carcinoma (Hepatoma)
01/2020 - 11/2004
2Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 12/2018
2Hyperkalemia
08/2019 - 12/2018
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2017 - 03/2002
2Obesity
01/2017 - 05/2004
2Myocardial Infarction
08/2016 - 05/2002
2Pain (Aches)
01/2008 - 12/2006
2Fibrosis (Cirrhosis)
01/2007 - 11/2004
1Brain Diseases (Brain Disorder)
11/2020
1Acute Coronary Syndrome
01/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Respiratory Sounds (Crackle)
12/2018
1Multiple Sclerosis
12/2018
1Neurologic Manifestations (Neurological Manifestations)
01/2017
1Hypertension (High Blood Pressure)
04/2015
1Dyslipidemias (Dyslipidemia)
04/2015
1Hypoxia (Hypoxemia)
07/2014
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
07/2014
1Atrial Fibrillation
06/2013
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2012
1Respiratory Insufficiency (Respiratory Failure)
10/2012

Drug/Important Bio-Agent (IBA)

9Pharmaceutical PreparationsIBA
01/2022 - 05/2002
8Warfarin (Coumadin)FDA LinkGeneric
01/2020 - 04/2002
6Cytochrome P-450 CYP2C9IBA
01/2017 - 04/2002
5Hepatitis B e AntigensIBA
03/2008 - 01/2007
4AnticoagulantsIBA
01/2020 - 04/2002
4Lamivudine (Epivir)FDA Link
03/2008 - 01/2007
3IpilimumabIBA
12/2021 - 01/2019
3Naloxone (Narcan)FDA LinkGeneric
11/2021 - 10/2019
3Opioid Analgesics (Opioids)IBA
11/2021 - 12/2006
3Rituximab (Mabthera)FDA Link
05/2021 - 10/2018
3obinutuzumabIBA
05/2021 - 10/2018
3Tissue Plasminogen Activator (Alteplase)FDA Link
01/2017 - 01/2013
2serum P-component (CIt)IBA
12/2021 - 11/2021
2GalliumIBA
05/2021 - 01/2019
2CannabidiolIBA
01/2021 - 11/2020
2patiromerIBA
08/2019 - 12/2018
2Spironolactone (Aldactone)FDA LinkGeneric
08/2019 - 12/2018
2Tumor Biomarkers (Tumor Markers)IBA
01/2015 - 05/2013
2Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2014 - 01/2011
2Tyrosine Kinase InhibitorsIBA
11/2009 - 01/2009
2ErbB Receptors (EGF Receptor)IBA
11/2009 - 01/2009
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2004 - 05/2002
2SolutionsIBA
09/2003 - 06/2002
2Povidone-Iodine (Betadine)FDA LinkGeneric
09/2003 - 06/2002
2chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric
09/2003 - 06/2002
1alectinibIBA
01/2022
1Anaplastic Lymphoma KinaseIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Biosimilar PharmaceuticalsIBA
05/2021
1Immunologic Factors (Immunomodulators)IBA
01/2020
1Prothrombin (Factor II)IBA
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Investigational DrugsIBA
01/2019
1Alemtuzumab (Campath)FDA Link
12/2018
1Interleukin-17 (Interleukin 17)IBA
12/2018
1Methotrexate (Mexate)FDA LinkGeneric
12/2018
1Bendamustine HydrochlorideFDA Link
10/2018
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2017
1Vincristine (Oncovin)FDA LinkGeneric
03/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2017
1omega-Chloroacetophenone (Mace)IBA
08/2016
1Carcinoembryonic AntigenIBA
01/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2014
1Epoprostenol (Prostacyclin)FDA LinkGeneric
07/2014
1Phenprocoumon (Liquamar)FDA Link
06/2013
1factor V LeidenIBA
05/2013

Therapy/Procedure

19Therapeutics
05/2021 - 04/2002
9Drug Therapy (Chemotherapy)
12/2021 - 05/2002
4Catheters
11/2004 - 06/2002
3Adjuvant Chemotherapy
04/2010 - 07/2005
2Immunotherapy
12/2021 - 11/2021
2Secondary Prevention
11/2009 - 05/2002
2Hospice Care (Care, Bereavement)
01/2008 - 12/2006
2Central Venous Catheters
11/2004 - 05/2004
2Vascular Access Devices (Arterial Line)
09/2003 - 06/2002
1Salpingo-oophorectomy
10/2020
1Mastectomy (Mammectomy)
10/2020
1Phototherapy (Light Therapy)
12/2018
1Stents
08/2016
1Chest Tubes (Chest Tube)
10/2012